UNSPSC 50501707: Glutamine

This classification denotes a non-essential amino acid and dietary amino acid with the molecular formula C5H10N2O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 0RH81L854J, chemically known as 2,5-diamino-5-oxopentanoic acid but more generally known as glutamine, which bears U.S. NIH Compound Identifier 738. European Medicines Agency schedules Glutamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB23331.

World Health Organization schedules glutamine in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 50501707 Glutamine is a Commodity code tracking state and local procurement of the amino acid glutamine, a nutritional supplement and therapeutic agent used in medical, clinical, and dietary applications. State and local governments purchase glutamine primarily through health departments, correctional facilities, medical examiner offices, and institutional food-service operations; the code also captures procurement by school districts, municipal hospitals, and specialized treatment centers. Glutamine is sourced as a powder, liquid concentrate, or capsule formulation and is specified in contracts for inpatient nutrition support, wound-healing protocols, immune-system supplementation in high-stress patient populations, and dietary enrichment in institutional meal programs. Buyers typically solicit glutamine through IFB or RFQ processes paired with standing supply agreements or periodic delivery schedules.

The recent-opportunities block contains no records for this code, indicating minimal state and local procurement activity under UNSPSC 50501707 in the current market window. The absence of recent solicitations suggests that glutamine purchases are either consolidated under broader nutritional-supplement or pharmaceutical codes, procured through cooperative purchasing vehicles or blanket agreements that do not generate individual notices, or handled through small-dollar operational spending that does not trigger formal bidding. Firms pursuing this commodity should monitor state health-department, correctional-services, and institutional-procurement channels directly and consider bundling glutamine into larger nutritional or medical-supply contracts where state and local buyers are actively seeking comprehensive vendor relationships.